Liver cirrhosis, a progressive condition characterized by liver scarring and impaired function, poses significant challenges to affected individuals. Among its many complications, sexual dysfunction can profoundly impact the quality of life for cirrhosis patients. In recent years, the use of Sildigra 100 Mg, a medication primarily indicated for erectile dysfunction (ED), has garnered attention as a potential treatment option for this population. This article delves into existing research to evaluate the efficacy and safety of Sildigra 100 in individuals with liver cirrhosis.